Détention brevets de la classe C07D 235/10

Brevets de cette classe: 111

Historique des publications depuis 10 ans

7
9
7
7
7
6
5
6
3
0
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
Glaxosmithkline LLC
533
5
Takeda Pharmaceutical Company Limited
2710
4
Kumiai Chemical Industry Co., Ltd.
313
4
Nippon Shinyaku Co., Ltd.
325
4
Merial, Inc.
216
3
Hoffmann-La Roche Inc.
3589
2
Arizona Board of Regents on behalf of Arizona State University
2772
2
Cornell University
3377
2
Dana-Farber Cancer Institute, Inc.
2637
2
Indiana University Research and Technology Corporation
797
2
Jiangsu Hengrui Medicine Co., Ltd.
701
2
Nanjing Tech University
278
2
Pharmacyclics, Inc.
102
2
Shanghai Hengrui Pharmaceutical Co., Ltd.
664
2
The United States of America, as represented by the Secretary, Department of Health and Human Services
2936
2
Vectus Biosystems Limited
31
2
Adamed Pharma S.A.
150
2
Vitae Pharmaceuticals, LLC
39
2
Xiamen Vivohealths Technology Co., Ltd.
7
2
Plex Pharmaceuticals, Inc.
17
2
Autres propriétaires 61